Our in vitro experiments indicated that the inhibition of FAM111B resulted in reduced cellular proliferation, migration, invasion, and EMT in ovarian cancer cell lines and in the suppression of tumor growth in a mouse xenograft model. Here, FAM111B is linked to neoplasm.